Oklahoma City enjoys a notable selection of area practitioners who are approved to write prescriptions for suboxone for the treatment of moderate opiate dependence. Opioid addiction causes a number of uncomfortable withdrawal symptoms which eventually produce a loss in a person’s ability to meet important daily responsibilities. Suboxone contains buprenorphine which is the opioid agonist that eliminates opioid withdrawal. Suboxone is more available now and is widely regarded in the medical community as a highly effective pharmaceutical intervention for mild to moderate opioid addiction. If you are a local physician who treats Oklahoma City area residents, you may purchase a featured listing at the top of this page insuring that your medical services will be found by prospective patients searching our website for quality opioid treatment.
Acadia Healthcare is a leading behavioral healthcare services provider headquartered out of Franklin, Tennessee. The company was established in 2005 and has experienced rapid growth as a result of strategic acquisitions and a sharp focus on the delivery of psychiatric and chemical dependency treatment services.
Acadia recently bought out CRC Health Group for a reported $1.2 billion in a well-publicized sale which closed in February 2015. The acquisition significantly expanded Acadia’s opioid addiction treatment capabilities adding approximately 82 methadone/suboxone facilities nationwide. The company is nicely positioned to serve tens of thousands of patients on a daily basis who are struggling with opioid addiction and other associated illnesses. Methadone and buprenorphine products are utilized in association with a variety of counseling approaches.
Acadia’s mission statement:
Right Path is an opioid treatment provider operating in the greater Hampton Roads area of eastern Virginia. The organization specializes in the use of burprenorphine (the critical ingredient in Suboxone that alleviates opioid withdrawal symptoms).
Right Path currently have outpatient services in Virginia Beach, Newport News, and Suffolk, but plan to soon offer a location convenient for residents and visitors along the Outer Banks.
Recognizing the importance of individualized treatment plans, Right Path tailor their services to the needs of the individual patient. While suboxone is beneficial in eliminating the pain of opioid withdrawal, addiction counseling is essential in helping patients to understand the addiction and recovery process. Right Path provide addiction counseling as a component of their overall treatment program.
Evening and weekend hours are offered, and most insurance is accepted. The Right Path website has a helpful page that outlines various questions and issues that you might cover with your Suboxone Doctor in your first appointment. Their website … Read more
Evzio is an FDA-approved emergency treatment that counteracts the effects of opioid overdose. It is an “auto-injector” designed to contain a retractable needle and a 0.4 mg dose of naloxone. Naloxone is a powerful opioid antagonist that reverses the effects of overdose with heroin or other opiates. Naloxone has been used throughout the country in the past few years and literally saved hundreds of lives.
Kaleo Pharma is the manufacturer of Evzio. The company specializes in innovative solutions for serious and life threatening medical conditions. Kaleo Pharma is based out of Richmond, Virginia, USA.
As has been documented in national media, very potent forms of heroin have become available much of it laced with other opiate derivatives like fentanyl. These combinations have proven lethal in a large number of cases often with younger people being the victims of overdose due to not understanding the extreme potency of the drugs being sold.
Products like Evzio in the hands of family and … Read more
Paul LePage, the governor of Maine, has announced that he is considering ceasing state-funded support for methadone. As an alternative, Maine is proposing that patients prescribed methadone be switched to a more affordable suboxone option as part of a $727,000 state budget cut. The story is here.
This is an indefensible decision with dire medical implications for opioid addicted patients currently receiving methadone. It equates to government officials making medical decisions that will negatively impact the health and well-being of thousands of people.
Representative Drew Gattine (a member of the Health & Human Services Committee) is quoted as saying the proposal shows a lack of understanding of the societal costs of addiction throughout the state of Maine.
Methadone and suboxone are both effective medications, but offer very unique characteristics and applications depending on the severity & chronicity of a patient’s opioid addiction. Buprenorphine (the actual opioid agonist contained in suboxone) has a much lower ceiling effect than does methadone … Read more